Hopkins Janet Jill
Chief Medical Officer
Hopkins Janet Jill has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Hopkins Janet Jill is listed as Chief Medical Officer at Aura Biosciences, Inc. Inside the rolling window, Hopkins Janet Jill reported no open-market purchases and 2 open-market sales totaling $196K in AURA. The largest disclosed transaction in the window is a sale of 20,401 AURA shares on Feb 17, 2026, worth $103K.
Companies traded
Other insiders at AURA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$196K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hopkins Janet Jill made?
Hopkins Janet Jill has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Hopkins Janet Jill trade?
Hopkins Janet Jill has filed SEC Form 4 disclosures for 1 company, including AURA.
When was Hopkins Janet Jill's most recent SEC Form 4 filing?
Hopkins Janet Jill's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Hopkins Janet Jill's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hopkins Janet Jill is listed as Chief Medical Officer.
What is Hopkins Janet Jill's total buy and sell value in the current window?
Inside the rolling retention window, Hopkins Janet Jill bought $0 and sold $196K based on SEC Form 4 filings.
What was Hopkins Janet Jill's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,401 AURA shares on 2026-02-17, worth $103K, per SEC Form 4 filings.